telmisartan has been researched along with Schistosomiasis mansoni in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attia, YM; El-Khatib, AS; Elalkamy, EF; Hammam, OA; Mahmoud, SS | 1 |
1 other study(ies) available for telmisartan and Schistosomiasis mansoni
Article | Year |
---|---|
Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Benzimidazoles; Benzoates; Disease Models, Animal; Drug Therapy, Combination; Liver; Liver Cirrhosis; Male; Mice; PPAR gamma; Praziquantel; Schistosomiasis mansoni; Telmisartan; Treatment Outcome | 2013 |